Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Breast Carcinoma In Situ 2Weight Loss 1Paget's Disease, Mammary 1Neoplasms 1Fatigue 1Cognitive Dysfunction 1Carcinoma, Intraductal, Noninfiltrating 1Arthralgia 1

Interventions

Tamoxifen 1Medroxyprogesterone 1Docosahexaenoic Acids 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paget's Disease, Mammary × Docosahexaenoic Acids × Breast × Clear all
NCT01849250 2021-12-28

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

National Cancer Institute (NCI)

Phase 2 Completed
65 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡